GSK3 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3 inhibitor, covering 2009-11-11 to 2009-11-11. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s Disease [Phase 1, Phase 2]